Ganesh Kamath has recently been named head of market access for Tonix Pharmaceuticals, the company announced Tuesday.
Tonix is a fully-integrated biotechnology company with marketed products and a pipeline of development candidates based in Chatham.
Kamath worked at CuriaGlobal, serving as VP of FP&A, business development, and sales operations. He aimed at strengthening business development and operational performance. Prior to that, he was SVP and chief financial officer at Hutchmed International, where he established pricing governance frameworks and advanced market access strategies.
Tonix EVP Thomas Englese praised his experience and what it means for the company.
“Ganesh brings deep expertise in market access and a history of delivering results at leading global organizations,” he said. “As we prepare for the commercial launch of Tonmya and continue advancing our pipeline, his leadership in pricing, contracting, and payer engagement will help ensure patients have timely access to our therapies while driving operational momentum across the business.”
Earlier in his career, Kamath held senior leadership roles at Bayer HealthCare within finance and market access, overseeing strategic pricing, contracting, reimbursement and gross to net management across a portfolio of more than 25 brands.
